deramciclane has been researched along with nebivolol in 1 studies
| Studies (deramciclane) | Trials (deramciclane) | Recent Studies (post-2010) (deramciclane) | Studies (nebivolol) | Trials (nebivolol) | Recent Studies (post-2010) (nebivolol) |
|---|---|---|---|---|---|
| 40 | 10 | 2 | 6 | 0 | 3 |
| Protein | Taxonomy | deramciclane (IC50) | nebivolol (IC50) |
|---|---|---|---|
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 4.3118 | |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 7.1264 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
1 other study(ies) available for deramciclane and nebivolol
| Article | Year |
|---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |